Spinal Lesions as Clinical Manifestations of Plasma Cell Neoplasia.
multiple myeloma
solitary bone plasmacytoma
spine
surgery
survival
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
29 08 2022
29 08 2022
Historique:
received:
13
06
2022
revised:
26
08
2022
accepted:
27
08
2022
entrez:
22
9
2022
pubmed:
23
9
2022
medline:
24
9
2022
Statut:
epublish
Résumé
(1) Background: Plasma cell neoplasia can be separated into independent subtypes including multiple myeloma (MM) and solitary plasmacytoma of the bone (SBP). The first clinical signs patients present with are skeletal pain, most commonly involving ribs and vertebrae. (2) Methods: Retrospective analysis of 114 patients (38 female, 76 male) receiving spinal surgery from March 2006 until April 2020. Neurological impairments and surgical instability were the criteria for intervention in this cohort. Analysis was based on demographic data, Spinal Instability Neoplastic Score (SINS), location of the lesion, spinal levels of tumor involvement, surgical treatment, histopathological workup, adjuvant therapy, functional outcome, and overall survival (OS). (3) Results: The following surgical procedures were performed: posterior stabilization only in 9 patients, posterior stabilization and decompression without vertebral body replacement in 56 patients, tumor debulking and decompression only in 8 patients, anterior approach in combined approach without vertebral body replacement and without biopsy and/or without kyphoplasty in 33 patients, 3 patients received biopsies only, and 5 patients received kyphoplasty only. The histopathology diagnoses were MM in 94 cases and SBP in 20 cases. Median OS was 72 months (53.4-90.6 months). Preoperative KPSS was 80% (range 40-100%), the postoperative KPSS was 80% (range 50-100%). (4) Conclusions: Surgery for patients with plasma cell neoplasia is beneficial in case of neurological impairment and spinal instability. Moreover, we were able to show that patients with MM and a low number of spinal levels to be supplied have a better prognosis as well as a younger age at the time of the surgical intervention.
Identifiants
pubmed: 36135059
pii: curroncol29090490
doi: 10.3390/curroncol29090490
pmc: PMC9497614
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6236-6244Références
Spine (Phila Pa 1976). 2019 Jan 15;44(2):E117-E125
pubmed: 30005040
Blood. 2005 Nov 1;106(9):2977-81
pubmed: 16020506
Blood. 2008 Apr 15;111(8):4039-47
pubmed: 18268097
Radiother Oncol. 1997 Jan;42(1):43-7
pubmed: 9132825
Mayo Clin Proc. 2009 Dec;84(12):1095-110
pubmed: 19955246
J Clin Oncol. 2006 Jan 20;24(3):431-6
pubmed: 16365178
Leukemia. 2009 Oct;23(10):1691-7
pubmed: 19587704
N Engl J Med. 1990 Feb 22;322(8):494-500
pubmed: 2405271
Semin Oncol. 2016 Dec;43(6):676-681
pubmed: 28061985
Hematol Oncol. 2019 Apr;37(2):129-135
pubmed: 30334279
J Clin Oncol. 2005 May 20;23(15):3412-20
pubmed: 15809451
Blood. 2005 Jul 1;106(1):35-9
pubmed: 15761019
Br J Haematol. 2020 Nov;191(3):418-425
pubmed: 32367512
Lancet Oncol. 2014 Nov;15(12):e538-48
pubmed: 25439696
Haematologica. 2000 Jan;85(1):47-51
pubmed: 10629591
Blood. 2000 Jan 1;95(1):7-11
pubmed: 10607678
Lancet Oncol. 2011 Jul;12(7):617-9
pubmed: 21664869
Blood Cancer J. 2015 Oct 23;5:e363
pubmed: 26495860
J Neurosurg Spine. 2015 Mar;22(3):301-9
pubmed: 25575166
Leukemia. 2009 Aug;23(8):1528-34
pubmed: 19322205
Blood Cancer J. 2019 Feb 26;9(3):27
pubmed: 30808868
Ann Surg Oncol. 2014 Oct;21(11):3661-7
pubmed: 24819121
Acta Orthop Scand. 1992 Apr;63(2):192-4
pubmed: 1590056
Leukemia. 2011 Jun;25(6):906-8
pubmed: 21350560
Best Pract Res Clin Haematol. 2005;18(4):635-52
pubmed: 16026742
Int J Radiat Oncol Biol Phys. 1998 Jul 15;41(5):1063-7
pubmed: 9719116
Cancer. 1975 Sep;36(3):842-54
pubmed: 1182674
Eur Spine J. 2015 Aug;24(8):1761-7
pubmed: 25527401
N Engl J Med. 2017 Apr 6;376(14):1311-1320
pubmed: 28379796
N Engl J Med. 1999 Nov 18;341(21):1565-71
pubmed: 10564685
Clin Nephrol. 2001 Sep;56(3):207-10
pubmed: 11597035
J Clin Oncol. 2011 Aug 1;29(22):3072-7
pubmed: 21709187
Surg Oncol. 2016 Sep;25(3):178-83
pubmed: 27566020
Crit Care. 2004 Aug;8(4):R204-12
pubmed: 15312219
Lancet Oncol. 2016 Aug;17(8):e328-e346
pubmed: 27511158
Best Pract Res Clin Haematol. 2005;18(4):673-88
pubmed: 16026744
J Am Coll Dent. 2014 Summer;81(3):14-8
pubmed: 25951678
N Engl J Med. 2011 Mar 17;364(11):1046-60
pubmed: 21410373
Lancet. 2017 Feb 4;389(10068):519-527
pubmed: 28017406
J Neurosurg Spine. 2006 Aug;5(2):140-5
pubmed: 16925080
J Clin Oncol. 2015 Sep 10;33(26):2863-9
pubmed: 26240224
N Engl J Med. 2003 May 8;348(19):1875-83
pubmed: 12736280
Spine J. 2014 Apr;14(4):651-8
pubmed: 24161362
Clin Oncol (R Coll Radiol). 2004 Sep;16(6):405-13
pubmed: 15487132
Oncology (Williston Park). 2000 Jan;14(1):101-8, 111; discussion 111-2, 115
pubmed: 10680152
Spine (Phila Pa 1976). 2001 Feb 1;26(3):298-306
pubmed: 11224867